This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
By providing a cannabis grower and seller with previously forbidden bankruptcy protection, the Hacienda opinion strengthens the cannabis industry by arming it with a critical business tool, Steve Schain writes.
Mirroring legalized cannabis delta-9-THC's effects, delta-8-THC requires no license, is readily available, and is cutting into legalized cannabis’ revenue despite growing state illegality, confusion over federal legality, and concerns regarding these products’ safety and potency, Steve Schain writes.
If cannabis is reclassified to Schedule III, cannabis businesses won't be encumbered by onerous operating and taxing obstacles, federally-funded cannabis research will finally occur, and investment will soar, writes Steve Schain.
Alaska’s allowance of vending infused dairy butters, oils and fats clears the way for a broader array of infused-product offerings nationally and a more consumer-driven market.
Hemp-derived THC is readily available online and over-the-counter, and is cutting into legalized cannabis’ revenue despite growing state illegality, confusion over federal legality, and concerns regarding untested and unregulated products’ safety and potency.
Despite lessening criminal and administrative penalties and depository insurance obstacles, both the SAFE Banking Act and pending state cannabis banking legislation fail to put legal cannabis on an equal footing with other legitimate industries.
With cannabis-derived products outpacing the existing science and imposing massive health concerns, in October 2021 the FDA issued a “Cannabis-derived products data acceleration plan” to detect safety signals and accelerate research studies.
Sales of foods and beverages infused with delta-8-THC are exploding, creating concerns regarding these untested and unregulated products’ safety and potency.
With federal legalization looming, and a dazzling array of "infused edibles" on the verge of dominating the shelves, grasping the complex cannabis regulatory landscape and the intricacies of patents, trade secrets, and federal and state trademarks is essential to ensuring growth, fortifying assets, and nurturing future business opportunities.